Cinctive Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.1K Sell
16,863
-230,071
-93% -$540K ﹤0.01% 351
2025
Q4
$669K Sell
246,934
-5,003
-2% -$16.4K 0.04% 311
2025
Q3
$1.07M Buy
251,937
+161,937
+180% +$712K 0.05% 299
2025
Q2
$448K Buy
+90,000
New +$391K 0.02% 318
2021
Q1
Sell
-33,307
Closed -$1.34M 437
2020
Q4
$1.34M Sell
33,307
-59,327
-64% -$2.73M 0.11% 251
2020
Q3
$5.15M Buy
+92,634
New +$4.9M 0.45% 76

Other funds holding GDRX

Cinctive Capital Management's GDRX Position: Q1 2026 in Review

Cinctive Capital Management reduced its GoodRx Holdings (GDRX) stake by 93% in Q1 2026, selling an estimated $540K and leaving 16,863 shares worth $33.1K. The position accounts for ﹤0.01% of the portfolio, ranked #351.

Cinctive Capital Management first reported a position in GDRX in Q3 2020 and has held it in 6 quarters since. The position peaked at $5.15M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Cinctive Capital Management held 16,863 shares of GoodRx Holdings worth $33.1K as of Q1 2026.
  • Cinctive Capital Management sold 230,071 GoodRx Holdings shares in Q1 2026, an estimated $540K.
  • GoodRx Holdings made up ﹤0.01% of Cinctive Capital Management's portfolio in Q1 2026, its #351 holding.
  • Cinctive Capital Management first reported a position in GoodRx Holdings in Q3 2020 and has held it in 6 quarters since.
  • Cinctive Capital Management's GoodRx Holdings position peaked at $5.15M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.